跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,672 条关于
“argenx SE”
全部
2,672
临床试验
1,918
药物
237
机构
49
资讯
468
9个月前
argenx Discontinues Phase 3 UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease Following Futility Analysis
3天前
Sling Therapeutics Raises $123M Series C to Push Oral Thyroid Eye Disease Drug Into Phase 3
2年前
argenx Outlines 'Vision 2030' with Focus on Autoimmune Disease Therapies
8个月前
argenx Announces Leadership Transition as Karen Massey Set to Replace Tim Van Hauwermeiren as CEO
去年
Argenx Expands Partnership with Fujifilm Biotechnologies to Manufacture Efgartigimod in the U.S.
去年
Argenx's Myositis Trial Data Prompts Optimistic Outlook from Jefferies
去年
argenx Advances ARGX-119 to Registrational Study for Ultra-Rare Congenital Myasthenic Syndromes
去年
Argenx Showcases Long-term Efficacy and Safety Data for VYVGART at AAN 2025 Meeting
去年
VYVGART Achieves Primary Endpoint in Phase 3 Trial for AChR-Ab Seronegative Myasthenia Gravis
2年前
BioNTech Highlights Oncology Pipeline Progress and Strategic Investments in Q4 2023 Earnings Call
第 1 页,共 47 页
上一页
下一页